全文获取类型
收费全文 | 358篇 |
免费 | 16篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 3篇 |
妇产科学 | 2篇 |
基础医学 | 72篇 |
临床医学 | 36篇 |
内科学 | 87篇 |
皮肤病学 | 2篇 |
神经病学 | 28篇 |
特种医学 | 2篇 |
外科学 | 54篇 |
综合类 | 2篇 |
预防医学 | 14篇 |
眼科学 | 7篇 |
药学 | 27篇 |
中国医学 | 5篇 |
肿瘤学 | 20篇 |
出版年
2023年 | 5篇 |
2022年 | 21篇 |
2021年 | 48篇 |
2020年 | 23篇 |
2019年 | 17篇 |
2018年 | 28篇 |
2017年 | 7篇 |
2016年 | 10篇 |
2015年 | 17篇 |
2014年 | 15篇 |
2013年 | 13篇 |
2012年 | 19篇 |
2011年 | 22篇 |
2010年 | 14篇 |
2009年 | 6篇 |
2008年 | 17篇 |
2007年 | 24篇 |
2006年 | 16篇 |
2005年 | 21篇 |
2004年 | 10篇 |
2003年 | 9篇 |
2002年 | 8篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1995年 | 1篇 |
1992年 | 1篇 |
排序方式: 共有377条查询结果,搜索用时 265 毫秒
91.
Eroshina K Danishevski K Wilkinson P McKee M 《Journal of public health (Oxford, England)》2004,26(2):197-204
BACKGROUND: The process of industrialization of the USSR has left a legacy of widespread and often poorly controlled pollution which is widely believed to have adverse implications for health, in particular for respiratory disease among children. OBJECTIVES: To assess the relationship between area of residence and respiratory function in junior schoolchildren in different districts of Moscow. METHODS: A survey was conducted of 539 children aged 6-12 years who attend school and live in one of three districts of Moscow with varying ambient pollution levels. Spirometry [forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1)] was assessed at school by trained school health staff. Parents of the children completed a questionnaire asking about respiratory function and factors potentially associated with it, as well as about social and other factors that could influence respiratory development and the health status of their children. RESULTS: There was appreciable difference in the characteristics of the children from the three districts. Children from the lower pollutant districts were generally younger, had higher parental income, and were less frequently exposed to cigarette smoke at home. They were also less likely to report heavy lorry traffic in the streets outside their homes. After adjustment for age, gender and height the FVC was 7.6 per cent (3.6-11.5 per cent) lower in children from the medium pollution district and 9.9 per cent [95 per cent confidence interval (CI) 5.6-14.0 per cent] lower in children from the high pollution district compared with those in the least polluted district (p < 0.001 for trend). These differences were little affected by further adjustment for household income or exposure to household smoking. In contrast, FEV1 showed comparatively little variation across districts. The odds of a forced expiratory ratio (FER) <75 per cent were substantially lower in the high pollution compared with the low pollution district (odds ratio 0.10, 95per cent CI 0.03-0.32 after adjustment for age, gender and height), and there was clear evidence of a trend across pollution categories (p < 0.001). The frequency of reported allergy was also lower in the high pollution district. FVC increased, and the probability of a low FER decreased, with household income. CONCLUSION: Children from areas of high environmental pollution had lower lung capacity but also smaller risk of a low FER compared with those from cleaner areas. The extent to which these differences can be attributed to environmental pollution is unclear without more detailed study. However, socio-economic deprivation, which was associated with pollution, appears to be an important determinant of respiratory function although it was associated with a lower risk of an obstructive pattern of lung function tests. 相似文献
92.
Chistiakov DA Seryogin YA Turakulov RI Savost'anov KV Titovich EV Zilberman LI Kuraeva TL Dedov II Nosikov VV 《Journal of autoimmunity》2005,24(3):243-250
Type 1 diabetes (T1D) susceptibility locus, IDDM8, has been accurately mapped to 200 kilobases at the terminal end of chromosome 6q27. This is within the region which harbours a cluster of three genes encoding proteasome subunit beta 1 (PMSB1), TATA-box binding protein (TBP) and a homologue of mouse programming cell death activator 2 (PDCD2). In this study, we evaluated whether these genes contribute to T1D susceptibility using the transmission disequilibrium test of the data set from 114 affected Russian simplex families. The A allele of the G/A1180 single nucleotide polymorphism (SNP) at the PDCD2 gene, which was significant in its preferential transfer from parents to diabetic children (75 transmissions vs. 47 non-transmissions, chi2=12.85, P corrected=0.0038), was found to be associated with T1D. G/A1180 dimorphism and two other SNPs, C/T771 TBP and G/T(-271) PDCD2, were shown to share three common haplotypes, two of which (A-T-G and A-T-T) have been associated with higher development risk of T1D. The third haplotype (G-T-G) was related to having a lower risk of disease. These findings suggest that the PDCD2 gene is a likely susceptibility gene for T1D within IDDM8. However, it was not possible to exclude the TBP gene from being another putative susceptibility gene in this region. 相似文献
93.
Kiselyov K Kim JY Zeng W Muallem S 《Pflügers Archiv : European journal of physiology》2005,451(1):116-124
Since their identification in the concluding years of the last century, the mammalian transient receptor potential (canonical) (TRPC) channels have remained in the limelight as the primary candidates for the Ca2+ entry pathway activated by the hormones, growth factors, and neurotransmitters that exert their effect through activation of PLC. Although TRPC channels have been shown clearly to mediate, at least in part, receptor-activated Ca2+ entry in literally all cell types, several of their central characteristics, as recorded in expression systems using recombinant channels, differ from those of the native receptor-dependent Ca2+ influx channels. The present review attempts to highlight the interaction of TRPC channels with other proteins, which may explain the variability of TRPC channel activation and regulatory mechanisms observed with the native and recombinant channels. These include the homologous and heterotopous interactions of TRPC channel isoforms, the interaction of TRPC channels with calmodulin, PLC, IP3 receptors, and with scaffolding proteins like InaD, EBP50/NEHRF, caveolin, Janctate and Homers. 相似文献
94.
A cluster of imprinted genes on human chromosome 15q11-q13 (the PWS/AS domain) and its ortholog on mouse chromosome 7c is believed to be regulated by an imprinting control center. Although minideletions in this region in Angelman syndrome (AS) and Prader-Willi syndrome (PWS) patients revealed that two elements, shortest deletion regions of overlap in AS families and PWS families (AS-SRO and PWS-SRO), respectively, constitute the IC, the molecular mechanism that governs this regional control remains obscure. To understand how this imprinting center works, a mouse model was sought. The striking similarity between the human and mouse sequences allowed the generation of a minitransgene (AS-SMP) composed of AS-SRO and the Snrpn minimal promoter (SMP) the mouse ortholog of PWS-SRO. This minitransgene carries out, in a highly reliable and reproducible manner, all steps of the imprinting process. In an attempt to decipher the molecular mechanism of the imprinting process, we generated and tested for imprinting five minitransgenes based on AS-SMP, in which various parts of the 160 bp SMP were deleted. These experiments revealed a set of five cis elements that carry out the various steps of the imprinting process. This set includes: (i). two copies of a de novo methylation signal (DNS) that establish the maternal imprint during oogenesis; (ii). an allele discrimination signal that establishes the paternal imprint; and (iii). two elements that act together to maintain the paternal imprint. Two functionally redundant sets of the five elements were found on the respective endogenous mouse sequence explaining the previously published contradictory results of targeted deletion experiments. Together with the fact that all five elements bind specific proteins that are presumably the factors acting in trans in the imprinting process, our observations set the stage for a comprehensive study of the molecular mechanism involved in the control of the imprinting process. 相似文献
95.
Musa Khaitov Alexandra Nikonova Igor Shilovskiy Ksenia Kozhikhova Ilya Kofiadi Lyudmila Vishnyakova Alexander Nikolskii Pia Gattinger Valeria Kovchina Ekaterina Barvinskaia Kirill Yumashev Valeriy Smirnov Artem Maerle Ivan Kozlov Artem Shatilov Anastasiia Timofeeva Sergey Andreev Olesya Koloskova Nadezhda Kuznetsova Daria Vasina Maria Nikiforova Sergei Rybalkin Ilya Sergeev Dmitriy Trofimov Alexander Martynov Igor Berzin Vladimir Gushchin Aleksey Kovalchuk Sergei Borisevich Rudolf Valenta Rakhim Khaitov Veronica Skvortsova 《Allergy》2021,76(9):2840-2854
Background
First vaccines for prevention of Coronavirus disease 2019 (COVID-19) are becoming available but there is a huge and unmet need for specific forms of treatment. In this study we aimed to evaluate the anti-SARS-CoV-2 effect of siRNA both in vitro and in vivo.Methods
To identify the most effective molecule out of a panel of 15 in silico designed siRNAs, an in vitro screening system based on vectors expressing SARS-CoV-2 genes fused with the firefly luciferase reporter gene and SARS-CoV-2-infected cells was used. The most potent siRNA, siR-7, was modified by Locked nucleic acids (LNAs) to obtain siR-7-EM with increased stability and was formulated with the peptide dendrimer KK-46 for enhancing cellular uptake to allow topical application by inhalation of the final formulation – siR-7-EM/KK-46. Using the Syrian Hamster model for SARS-CoV-2 infection the antiviral capacity of siR-7-EM/KK-46 complex was evaluated.Results
We identified the siRNA, siR-7, targeting SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) as the most efficient siRNA inhibiting viral replication in vitro. Moreover, we showed that LNA-modification and complexation with the designed peptide dendrimer enhanced the antiviral capacity of siR-7 in vitro. We demonstrated significant reduction of virus titer and lung inflammation in animals exposed to inhalation of siR-7-EM/KK-46 in vivo.Conclusions
Thus, we developed a therapeutic strategy for COVID-19 based on inhalation of a modified siRNA-peptide dendrimer formulation. The developed medication is intended for inhalation treatment of COVID-19 patients.96.
Kirill V. Sukhoverkov Maxime G. Corral Julie Leroux Joel Haywood Philipp Johnen Trevor Newton Keith A. Stubbs Joshua S. Mylne 《RSC advances》2021,11(15):8459
Herbicides have physico-chemical properties not unlike orally-delivered human drugs, but are known to diverge in their limits for proton donors, partition coefficients and molecular weight. To further refine rules specific for herbicides, we exploited the close evolutionary relationship between Plasmodium falciparum and plants by screening the entire Malaria Box, a chemical library of novel chemical scaffolds with activity against the blood stage of P. falciparum. Initial screening against Arabidopsis thaliana on agar media and subsequently on soil demonstrated the crucial nature of log P and formal charge are to active molecules. Using this information, a weighted scoring system was applied to a large chemical library of liver-stage effective antimalarial leads, and of the six top-scoring compounds, one had potency comparable to that of commercial herbicides. This novel compound, MMV1206386, has no close structural analogues among commercial herbicides. Physiological profiling suggested that MMV1206386 has a new mode of action and overall demonstrates how weighted rules can help during herbicide discovery programs.Trawling hundreds of antimalarials for herbicides, we develop a weighted scoring system for the phys-chem ‘rules’ of herbicide-likeness. Using this, we discover the antimalarial MMV1206386 is herbicidal via a novel mode of action. 相似文献
97.
Vladimir T. Ivashkin Igor V. Maev Chavdar S. Pavlov Marina V. Mayevskaya Aleksey A. Samsonov Lyudmila K. Palgova Kirill M. Starostin 《The Turkish journal of gastroenterology》2021,32(9):750
Background: Essential phospholipids (EPL) are used as adjuvant treatment in people with fatty liver disease and other chronic liver diseases. A new formulation of EPL paste was developed to improve patient compliance. The study was aimed to assess the safety, patient-reported outcomes, and impact on compliance of the new EPL paste formulation in patients with non-alcoholic fatty liver disease (NAFLD) or viral hepatitis.Methods: The study enrolled 147 patients (48.3% male; mean ± standard deviation (SD) age 44.8 ± 10.5 years) in the intention-to-treat population; 72.8% had NAFLD and 27.9% had viral hepatitis B (HBV) or hepatitis C (HCV). Patients received EPL paste (one 600 mg sachet 3 times daily) for 12 weeks, with 4-, 8-, and 12-week scheduled visits and a 13-week follow-up visit. Patient-reported outcomes were evaluated at 4, 8, and 12 weeks compared with baseline using dedicated Likert scales. Compliance was assessed by comparing actual versus prescribed dosing of the EPL.Results: After 12-week treatment with EPL paste, statistically significant improvements were observed in mean ± SD Global Overall Symptom scores (from 4.21 ± 1.09 to 1.87 ± 0.91; P < .01) and overall Gastrointestinal Symptom scores (from 19.91 ± 5.74 to 11.17 ± 3.57; P < .01), compared to baseline scores. Compliance with prescribed essential phospholipid treatment was 99% throughout the 12-week treatment period.Conclusion: Essential phospholipids paste had a favorable safety profile associated with improved gastrointestinal symptoms and with high levels of compliance in patients with NAFLD and viral hepatitis. 相似文献
98.
For the first time, yttrium triflate was used as an efficient green catalyst for the synthesis of α-aminophosphonates through a one-pot three-component Birum–Oleksyszyn reaction. Under the action of this Lewis acid, enhancement of the yield and reaction chemoselectivity was provided by the achievement of an appropriate balance in the complex network of reactions.For the first time, yttrium triflate was used as an efficient green catalyst for the synthesis of α-aminophosphonates through a one-pot three-component Birum–Oleksyszyn reaction.Multicomponent reactions are commonly used to achieve molecular complexity. In particular, one-pot three-component reactions have been exploited for the synthesis of α-aminophosphonates. These organophosphorus compounds have attracted the attention of medicinal chemists due to their similarity to α-amino acids. They find application in agriculture as plant growth regulators1 and herbicides,2 in medicinal chemistry as antibacterial,3,4 antiviral5 and antitumor agents,6 activity-based probes,7 and building blocks for peptides and proteins.8 Since the first preparation of α-aminophosphonates, reported in 1952 by Fields,9 various methods for their synthesis have been proposed.10–16 Nowadays, one-pot three-component condensation of aldehyde, amine, and phosphite, catalyzed by an excess of acetic acid, is the most common method due to its simplicity and, in general, high yields of products.4 Application of Lewis acids as the catalyst instead of Brønsted acids was first reported in 1973 by Birum.17 The advantage of Lewis acids is their compatibility with acid-sensitive functional groups that, under typical conditions (glacial acetic acid) would be degraded.Condensation of aldehyde, carbamate, and triaryl phosphite has been named as Birum–Oleksyszyn reaction.18 Recently, a new biologically active α-aminophosphonate (UAMC-00050) was developed at the University of Antwerp.19–21 This diarylphosphonate shows good inhibitory activity against urokinase plasminogen activator (uPA), an enzyme involved in several physiological processes, such as tissue remodeling.22 uPA can be also involved in the development of different diseases, for example, thrombolytic disorder,23 cancer,24 and eye diseases.25 UAMC-00050 is currently under investigation for the treatment of irritable bowel syndrome26 and dry eye disease.21 The key step of the synthesis of UAMC-00050, proposed by Joossens et al.,19,21 involves Birum–Oleksyszyn reaction, catalyzed by Cu(OTf)2 in acetonitrile, which, on a small scale, provides 20% yield of the product (Scheme 1). In current work, a new catalyst has been introduced for the Birum–Oleksyszyn reaction. For the first time, we report the use of yttrium salt in a one-pot three-component synthesis of α-aminophosphonates, which provides a remarkable improvement of the yield of product for the key step in the synthesis of UAMC-00050. The scope of the protocol has been demonstrated on a variety of aldehydes, phosphites, and carbamates.Open in a separate windowScheme 1Conditions for the preparation of intermediate 4 in the synthesis of UAMC-00050 (5).In the frame of the dry eye disease drug development (IT-DED3) project,27 we have worked toward upscaling of the synthetic route and providing larger amounts of UAMC-00050 for more detailed research of its biological activity.During our attempts to upscale the key step to 3.0 g scale, we noticed a considerable decrease of the yield of product from 20% to 11%. In our view, the poor outcome of the process cannot be attributed to the Birum–Oleksyszyn reaction alone. The nature of substituents in the target molecule affects the overall efficiency of the transformation through both the main and a number of side reactions (Scheme 2). This three-component reaction involves unstable paracetamol phosphite 1, aliphatic aldehyde 2 bearing Boc-protected amino group, and benzyl carbamate 3 (Scheme 1). In general, aliphatic aldehydes are less reactive in Birum–Oleksyszyn reaction, which consequently requires a stronger catalyst or longer reaction time to achieve satisfactory yield of product.15,28 The imine generated from the condensation of carbamate and aldehyde is highly reactive and can add a second molecule of carbamate forming aminal 7.29 Compound 7 can participate in Arbuzov-type reactions,30 if, as hypothesized, it is converted into reactive cation 13 by Brønsted29 or Lewis acid.31 However, Lewis acid-catalyzed reactions of aminal 7 or its analogs and triaryl phosphites are not known.Open in a separate windowScheme 2Birum–Oleksyszyn reaction as the key step and possible side reactions in the synthesis of UAMC-00050.The presence of paracetamol moiety complicates the synthesis due to the lower stability of its phosphorus esters both in starting triaryl phosphite and in the formed α-aminophosphonate. In the reaction environment, they readily hydrolyze with one equivalent of water formed in the condensation of aldehyde 2 and the carbamate 3 generating diarylphosphite 9 and monoaryl side product 10.As previously reported, product 4 is stable in the presence of water.21 However, under the reaction conditions, hydrolysis proceeds with the help of the Lewis acid.32 With prolonged reaction time (i.e., 24 h) we noticed a decrease in the yield of product 4 almost in half compared to the yield obtained in the reaction performed for 4 h and formation of acid 10 as the major side product.Application of N-Boc-protected starting material is also challenging, since, in the presence of a Lewis acid catalyst, partial removal of the Boc group takes place and unprotected amino aldehyde 11 forms black-brown polymer 12 (Scheme 2).Improving the overall efficiency of the synthesis of α-aminophosphonate 4 requires simultaneous promotion of imine formation and Birum–Oleksyszyn reaction and suppression of unwanted hydrolysis and Boc group removal. In search for optimal conditions, we initiated screening of various acidic catalysts using equimolar ratio (1 : 1 : 1) of aldehyde 2, carbamate 3, and phosphite 1 with 10 mol% load of the catalyst in MeCN performing the reaction at room temperature for 4 h.19 Acetonitrile proved to be an optimal solvent for the preparation of 4, it is polar enough to dissolve all the starting materials, it is not a concern for the environment, like DCM, and it does not hydrolyze the product like protic solvents: MeOH, EtOH and H2O.In Entry Catalyst Yield of product 4, %b Ratio 4/10 Selectivity, %c 1 AcOHd 0 0 : 100 0 2 TiCl4 8 44 : 66 44 3 ZrCl4 8 81 : 19 81 4 Cu(OTf)2 11 76 : 24 76 5 BiCl3 13 74 : 26 74 6 TfOH 13 82 : 18 82 7 Mg(OTf)2 14 50 : 50 50 8 FeCl3 15 68 : 32 68 9 LiOTf 15 85 : 15 85 10 Sc(OTf)3 16 81 : 19 81 11 Et2O·BF3 16 76 : 24 76 12 Bi(NO3)3·5H2O 19 76 : 24 76 13 Yb(OTf)3 20 67 : 33 67 14 SnCl4 22 57 : 43 57 15 ZnCl2 22 81 : 19 81 16 La(OTf)3 25 69 : 31 69 17 Bi(OTf)3 31 76 : 24 76 18 AcOH 35 54 : 46 54 19 Y(OTf)3 42 80 : 20 80 20 Y(OTf)3e 17 84 : 16 84 21 Y(OTf)3f 31 66 : 34 66